Zoetis | ZTS - Gross Profit On Sales




Zoetis reported $1.61B in Gross Profit on Sales for its fiscal quarter ending in December of 2024.

Gross Profit On Sales Change Date
AbbVie USD 10.71B 458M Dec/2024
Align Technology USD 696.94M 15.17M Dec/2024
Bayer EUR 4.88B 1.27B Sep/2024
Bristol-Myers Squibb USD 7.53B 1.4B Dec/2024
Charles River Laboratories USD 367.77M 36K Sep/2024
Dentsply International USD 495M 16M Sep/2024
Eli Lilly USD 11.13B 10.16B Dec/2024
Henry Schein USD 993M 25M Sep/2024
Idexx Laboratories USD 570.66M 25.38M Dec/2024
Illumina USD 728M 17M Dec/2024
IQVIA Holdings USD 1.38B 463M Dec/2024
J&J USD 15.58B 69M Dec/2024
Laboratory Of America USD 896.3M 8.1M Dec/2024
Merck USD 11.8B 1.61B Dec/2024
Neogen USD 113.33M 8.4M Nov/2024
Pacira USD -143466000 275.31M Sep/2024
Patterson Companies USD 328.09M 0 Oct/2024
Perrigo USD 404.4M 9.7M Sep/2024
Pfizer USD 12.02B 418M Dec/2024
Quest Diagnostics USD 858M 42M Dec/2024
Sanofi EUR 10.07B 2.1B Sep/2024
Sanofi EUR 10.07B 2.1B Sep/2024
Zoetis USD 1.61B 928M Dec/2024